| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Medcamp S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.60 |
| 52 Week High | zł1.22 |
| 52 Week Low | zł0.54 |
| Beta | -7.66 |
| 1 Month Change | 0% |
| 3 Month Change | 0.67% |
| 1 Year Change | -37.50% |
| 3 Year Change | -78.87% |
| 5 Year Change | 106.90% |
| Change since IPO | -94.58% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDP | PL Real Estate | PL Market | |
|---|---|---|---|
| 7D | -3.2% | 0.7% | -0.7% |
| 1Y | -37.5% | 14.0% | 24.7% |
Return vs Industry: MDP underperformed the Polish Real Estate industry which returned 14% over the past year.
Return vs Market: MDP underperformed the Polish Market which returned 24.7% over the past year.
Price Volatility
| MDP volatility | |
|---|---|
| MDP Average Weekly Movement | 11.5% |
| Real Estate Industry Average Movement | 4.8% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in PL Market | 9.7% |
| 10% least volatile stocks in PL Market | 3.1% |
Stable Share Price: MDP has not had significant price volatility in the past 3 months.
Volatility Over Time: MDP's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Polish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Cezary Ziarkowski | medcampsa.pl |
Medcamp S.A. engages in the real estate business. The company also offers basic inorganic and organic chemicals; pharmaceutical substances; management consultancy services; financial services, such as fund management; engineering and related technical consultancy; and research and development services. Medcamp S.A. was formerly known as T2 Investment SA.
Medcamp S.A. Fundamentals Summary
| MDP fundamental statistics | |
|---|---|
| Market cap | zł15.69m |
| Earnings (TTM) | -zł2.05m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-7.7x
P/E RatioIs MDP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDP income statement (TTM) | |
|---|---|
| Revenue | zł0 |
| Cost of Revenue | zł7.68k |
| Gross Profit | -zł7.68k |
| Other Expenses | zł2.04m |
| Earnings | -zł2.05m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 13, 2024
| Earnings per share (EPS) | -0.078 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 2.8% |
How did MDP perform over the long term?
See historical performance and comparison